NE MPJE study materials
NE MPJE study resources

A 16-Year-Old, Isotretinoin, and a Confidentiality Request

NE MPJE · Put your knowledge to work in context.

All case studies

A 16-Year-Old, Isotretinoin, and a Confidentiality Request

A 16-year-old presents at a Nebraska pharmacy with a prescription for isotretinoin 40 mg twice daily for 30 days, dated nine days earlier by a dermatologist across the state line. The pharmacy is not enrolled in the iPLEDGE program; the prescriber's office says the staff "will get the authorization entered today" and asks the pharmacist to fill in the meantime. The teen's mother is present, wants the prescription filled, and asks whether her daughter has picked up anything else this month. Earlier that week the teen privately asked the pharmacist not to tell her mother about a doxycycline prescription that the teen pays for herself; that prescription has not yet been filled. The pharmacy's profile shows an earlier isotretinoin course 14 months ago. No acne-related counseling is documented for this prescription, and the pharmacist has about 20 minutes before closing.

1. Can the pharmacy dispense the isotretinoin today? Explain the program requirements that apply and how the pharmacist should respond to the prescriber's office.

Read the worked answer

No. This prescription cannot be dispensed here today, for two separate reasons.

First, isotretinoin is available only through a shared-system REMS (iPLEDGE). Only pharmacies enrolled and certified in the program may dispense it; the prescriber must be registered and the patient registered, and each dispensing requires the pharmacist to obtain an authorization from the system. A pharmacy that is not enrolled has no lawful pathway to dispense, regardless of what the prescriber's office promises.

Second, even if the pharmacy were enrolled, the timing fails. Dispensing must occur within the required window after the qualifying pregnancy test and office visit - a prescription dated nine days earlier falls outside that window, so the authorization would not be obtainable. An "emergency" or partial supply does not exist for this drug.

Handling the office: state plainly that the pharmacy is not certified and cannot dispense until it is, and that the prescription will also need to be reissued within the dispensing window. Do not accept a verbal assurance that "it's being entered." Refer the patient to a certified pharmacy, or begin the enrollment process and explain the timeline honestly. Document the conversation, the enrollment status, and the referral. Enrolling a pharmacy is a process, not a same-day workaround, and the pharmacist should not hold the prescription while the 30-day supply of a teratogen sits unresolved.

2. The mother asks whether her daughter has picked up anything else, and the teen has asked for confidentiality on the doxycycline. How should the pharmacist reason through this?

Read the worked answer

This is a state-law question with a HIPAA overlay, and the pharmacist must not improvise at the counter.

HIPAA generally treats a parent as the personal representative of an unemancipated minor, which would permit disclosure of the minor's protected health information. But HIPAA defers to state law on who may consent to a minor's care. Where Nebraska law permits a minor to consent to a particular service on her own, the parent is not automatically the personal representative for records of that service, and the minor's confidentiality request can control. Where the minor could not have consented independently, the parent generally is the personal representative.

Practical reasoning for this counter:

  • Do not confirm or deny anything while the issue is unresolved; a vague answer is still a disclosure.
  • Determine whether the doxycycline was obtained through a service the teen could lawfully consent to on her own. If not, the pharmacist should follow the pharmacy's written policy on parental access rather than making an ad hoc exception.
  • Tell the teen privately what the pharmacist can and cannot keep confidential before promising anything. A promise that cannot be kept is worse than an honest limitation.
  • Disclose only the minimum necessary.

Separately, the isotretinoin conversation with the mother is not a confidentiality problem - the pharmacy simply cannot fill it, and that can be said to both of them.

3. If the patient transfers to a certified pharmacy that can dispense, what counseling and documentation must accompany the isotretinoin, and what role does this pharmacy play?

Read the worked answer

Even where this pharmacy cannot dispense, it should counsel and document rather than let the patient leave with nothing.

Required counseling content:

  • Teratogenicity and the absolute need to avoid pregnancy; the requirement for a negative pregnancy test and use of two forms of contraception, and what to do if a dose is missed or pregnancy is suspected.
  • No sharing of medication and no blood donation during and for a period after therapy.
  • Avoidance of vitamin A supplements and tetracyclines; photosensitivity and sun protection.
  • Expected adverse effects: dryness of skin, lips, eyes; initial flare; and the need for monitoring of lipids and liver function.
  • Psychiatric and neurologic effects - mood change, suicidal ideation, pseudotumor cerebri symptoms - with instructions to contact the prescriber promptly.
  • The Medication Guide, and confirmation that the patient understands.

Documentation: the pharmacist should record that counseling was offered and provided, what was covered, who was present, and the patient's questions. In the REMS context the certified pharmacy documents the authorization and counseling in the system itself, so this pharmacy's note is a bridge, not a substitute.

This pharmacy's role: give the patient a clear referral, hand off the counseling information, and note in the profile that the prescription was not dispensed and why - so that if the patient returns with a new prescription, the record reflects the sequence.